Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Brainstorm Cell Therapeutics Inc. (BCLI) since 2007 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Brainstorm Cell Therapeutics Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1137883.
Total stock buying since 2007: $1,752,284.
Total stock sales since 2007: $1,893,555.
Total stock option exercises since 2007: $13,973,569,071.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 23,836 | $11,307 | 63,000 | $22,050 | 0 | $0 |
| 2023 | 11,500 | $20,401 | 0 | $0 | 0 | $0 |
| 2020 | 51,779 | $672,399 | 71,753 | $960,658 | 0 | $0 |
| 2019 | 19,075 | $74,264 | 13,332 | $48,888 | 13,332 | $29,997 |
| 2017 | 4,500 | $18,610 | 0 | $0 | 0 | $0 |
| 2015 | 61,200 | $173,708 | 81,822 | $216,168 | 5,000 | $3,750 |
| 2014 | 1,265,200 | $490,050 | 0 | $0 | 0 | $0 |
| 2011 | 300,000 | $85,400 | 1,083,324 | $340,127 | 10,499,999 | $1,259,999 |
| 2010 | 0 | $0 | 250,000 | $90,000 | 0 | $0 |
| 2009 | 0 | $0 | 775,000 | $205,664 | 0 | $0 |
| 2008 | 0 | $0 | 40,000 | $10,000 | 6,125,000 | $1,112,750 |
| 2007 | 200,000 | $206,145 | 0 | $0 | 12,181,925 | $13,971,162,575 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-10 | 1,836 | $6,291 | 0 | $0 | 0 | $0 |
| 2024-09 | 22,000 | $5,016 | 0 | $0 | 0 | $0 |
| 2024-07 | 0 | $0 | 63,000 | $22,050 | 0 | $0 |
| 2023-09 | 11,500 | $20,401 | 0 | $0 | 0 | $0 |
| 2020-07 | 51,779 | $672,399 | 71,753 | $960,658 | 0 | $0 |
| 2019-12 | 17,600 | $69,264 | 0 | $0 | 0 | $0 |
| 2019-08 | 0 | $0 | 13,332 | $48,888 | 13,332 | $29,997 |
| 2019-01 | 1,475 | $5,000 | 0 | $0 | 0 | $0 |
| 2017-08 | 4,500 | $18,610 | 0 | $0 | 0 | $0 |
| 2015-12 | 0 | $0 | 81,822 | $216,168 | 5,000 | $3,750 |
| 2015-10 | 2,000 | $5,160 | 0 | $0 | 0 | $0 |
| 2015-09 | 9,200 | $21,528 | 0 | $0 | 0 | $0 |
| 2015-08 | 50,000 | $147,020 | 0 | $0 | 0 | $0 |
| 2014-10 | 12,700 | $51,194 | 0 | $0 | 0 | $0 |
| 2014-09 | 32,900 | $66,776 | 0 | $0 | 0 | $0 |
| 2014-06 | 280,000 | $90,200 | 0 | $0 | 0 | $0 |
| 2014-04 | 939,600 | $281,880 | 0 | $0 | 0 | $0 |
| 2011-12 | 0 | $0 | 98,333 | $25,173 | 0 | $0 |
| 2011-11 | 0 | $0 | 10,000 | $2,700 | 0 | $0 |
| 2011-10 | 0 | $0 | 200,000 | $61,745 | 0 | $0 |
| 2011-07 | 0 | $0 | 100,000 | $45,500 | 0 | $0 |
| 2011-06 | 100,000 | $28,000 | 33,023 | $9,246 | 0 | $0 |
| 2011-05 | 200,000 | $57,400 | 71,650 | $21,495 | 0 | $0 |
| 2011-04 | 0 | $0 | 284,820 | $85,543 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-10-01 | Lebovits Chaim (President & CEO) | Buy | 1,836 | 3.43 | 6,291 |
| 2024-09-30 | Lebovits Chaim (President & CEO) | Buy | 22,000 | .23 | 5,016 |
| 2024-07-19 | Dagher Ibrahim B. (Chief Medical Officer) | Sale | 63,000 | .35 | 22,050 |
| 2023-09-01 | Lindborg Stacy (Co-Chief Executive Officer) | Buy | 11,500 | 1.77 | 20,401 |
| 2020-07-16 | Setboun David (EVP and COO) | Buy | 5,000 | 12.95 | 64,740 |
| 2020-07-16 | Acc International Holdings Ltd. | Sale | 7,823 | 13.47 | 105,352 |
| 2020-07-15 | Abbhi Sankesh | Buy | 46,779 | 12.99 | 607,659 |
| 2020-07-15 | Acc International Holdings Ltd. | Sale | 18,430 | 13.12 | 241,709 |
| 2020-07-13 | Acc International Holdings Ltd. | Sale | 40,000 | 13.52 | 540,960 |
| 2020-07-10 | Acc International Holdings Ltd. | Sale | 2,000 | 13.35 | 26,700 |
| 2020-07-09 | Acc International Holdings Ltd. | Sale | 3,500 | 13.12 | 45,937 |
| 2019-12-24 | Shah Preetam (EVP, CFO and Treasurer) | Buy | 11,600 | 3.96 | 45,924 |
| 2019-12-24 | Araya Arturo (Chief Commercial Officer) | Buy | 3,000 | 3.90 | 11,700 |
| 2019-12-24 | Kern Ralph Dr. (COO and Chief Medical Officer) | Buy | 3,000 | 3.88 | 11,640 |
| 2019-08-28 | Arbel Irit | Sale | 13,332 | 3.67 | 48,888 |
| 2019-08-28 | Arbel Irit | Option Ex | 13,332 | 2.25 | 29,997 |
| 2019-01-04 | Almenoff June Sherie | Buy | 1,475 | 3.39 | 5,000 |
| 2017-08-31 | Arbel Irit | Buy | 2,500 | 4.26 | 10,650 |
| 2017-08-23 | Yablonka Uri (EVP & Chief Business Officer) | Buy | 2,000 | 3.98 | 7,960 |
| 2015-12-16 | Shorr Robert G L | Sale | 10,800 | 2.71 | 29,268 |
| 2015-12-15 | Taub Malcolm S | Sale | 11,263 | 2.59 | 29,171 |
| 2015-12-14 | Friedman Mordechai | Sale | 5,000 | 2.57 | 12,850 |
| 2015-12-14 | Friedman Mordechai | Option Ex | 5,000 | .75 | 3,750 |
| 2015-12-14 | Taub Malcolm S | Sale | 30,479 | 2.61 | 79,550 |
| 2015-12-11 | Taub Malcolm S | Sale | 980 | 2.66 | 2,606 |
| 2015-12-11 | Shorr Robert G L | Sale | 5,300 | 2.56 | 13,568 |
| 2015-12-10 | Taub Malcolm S | Sale | 12,500 | 2.74 | 34,250 |
| 2015-12-10 | Shorr Robert G L | Sale | 5,500 | 2.71 | 14,905 |
| 2015-10-01 | Acc International Holdings Ltd. | Buy | 2,000 | 2.58 | 5,160 |
| 2015-09-30 | Acc International Holdings Ltd. | Buy | 9,200 | 2.34 | 21,528 |
| 2015-08-20 | Bibring Yoram (Chief Financial Officer) | Buy | 8,500 | 3.04 | 25,840 |
| 2015-08-17 | Bibring Yoram (Chief Financial Officer) | Buy | 41,500 | 2.92 | 121,180 |
| 2014-10-15 | Fiorino Anthony S. (Chief Executive Officer) | Buy | 500 | 3.60 | 1,797 |
| 2014-10-10 | Acc International Holdings Ltd. | Buy | 8,600 | 4.04 | 34,709 |
| 2014-10-01 | Acc International Holdings Ltd. | Buy | 3,600 | 4.08 | 14,688 |
| 2014-09-30 | Acc International Holdings Ltd. | Buy | 1,500 | 4.27 | 6,402 |
| 2014-09-29 | Acc International Holdings Ltd. | Buy | 1,600 | 4.16 | 6,651 |
| 2014-09-22 | Acc International Holdings Ltd. | Buy | 8,500 | 4.20 | 35,734 |
| 2014-09-19 | Acc International Holdings Ltd. | Buy | 2,500 | 3.92 | 9,800 |
| 2014-09-18 | Fiorino Anthony S. (Chief Executive Officer) | Buy | 800 | 3.84 | 3,072 |
| 2014-09-15 | Fiorino Anthony S. (Chief Executive Officer) | Buy | 8,000 | .29 | 2,288 |
| 2014-09-12 | Fiorino Anthony S. (Chief Executive Officer) | Buy | 10,000 | .28 | 2,829 |
| 2014-06-16 | Acc International Holdings Ltd. | Buy | 130,000 | .29 | 37,700 |
| 2014-06-13 | Acc International Holdings Ltd. | Buy | 150,000 | .35 | 52,500 |
| 2014-04-28 | Acc International Holdings Ltd. | Buy | 939,600 | .30 | 281,880 |
| 2011-12-05 | Shorr Robert G L | Sale | 98,333 | .26 | 25,173 |
| 2011-11-28 | Shorr Robert G L | Sale | 10,000 | .27 | 2,700 |
| 2011-10-05 | Shorr Robert G L | Sale | 95,000 | .30 | 28,880 |
| 2011-10-04 | Shorr Robert G L | Sale | 105,000 | .31 | 32,865 |
| 2011-07-08 | Taub Malcolm S (Director) | Sale | 100,000 | .46 | 45,500 |
| 2011-06-16 | Acc International Holdings Ltd. (Other) | Buy | 100,000 | .28 | 28,000 |
| 2011-06-06 | Taub Malcolm S (Director) | Sale | 33,023 | .28 | 9,246 |
| 2011-05-23 | Acc International Holdings Ltd. (Other) | Buy | 100,000 | .27 | 27,400 |
| 2011-05-18 | Acc International Holdings Ltd. (Other) | Buy | 100,000 | .30 | 30,000 |
| 2011-05-18 | Taub Malcolm S (Director) | Sale | 10,250 | .30 | 3,075 |
| 2011-05-17 | Taub Malcolm S (Director) | Sale | 61,400 | .30 | 18,420 |
| 2011-04-13 | Taub Malcolm S (Director) | Sale | 165,000 | .30 | 49,500 |
| 2011-04-12 | Taub Malcolm S (Director) | Sale | 3,000 | .30 | 900 |
| 2011-04-07 | Taub Malcolm S (Director) | Sale | 5,000 | .30 | 1,500 |
| 2011-04-05 | Taub Malcolm S (Director) | Sale | 97,966 | .30 | 29,487 |
| 2011-04-04 | Taub Malcolm S (Director) | Sale | 6,500 | .30 | 1,950 |
| 2011-04-01 | Taub Malcolm S (Director) | Sale | 7,354 | .30 | 2,206 |
| 2011-03-31 | Taub Malcolm S (Director) | Sale | 20,000 | .30 | 6,000 |
| 2011-03-22 | Taub Malcolm S (Director) | Sale | 43,630 | .30 | 13,089 |
| 2011-03-14 | Taub Malcolm S (Director) | Sale | 40,400 | .30 | 12,322 |
| 2011-03-10 | Taub Malcolm S (Director) | Sale | 50,000 | .31 | 15,500 |
| 2011-03-09 | Taub Malcolm S (Director) | Sale | 50,000 | .31 | 15,500 |
| 2011-03-08 | Taub Malcolm S (Director) | Sale | 81,468 | .32 | 26,314 |
| 2011-01-23 | Accbt Corp. (10% Owner) | Option Ex | 10,499,999 | .12 | 1,259,999 |
| 2010-02-22 | Stolick David (Chief Financial Officer) | Sale | 100,000 | .36 | 36,000 |
| 2010-02-17 | Stolick David (Chief Financial Officer) | Sale | 2,000 | .36 | 720 |
| 2010-02-16 | Stolick David (Chief Financial Officer) | Sale | 143,000 | .36 | 51,480 |
| 2010-02-12 | Stolick David (Chief Financial Officer) | Sale | 5,000 | .36 | 1,800 |
| 2009-10-26 | Shorr Robert G L (Director) | Sale | 40,000 | .31 | 12,440 |
| 2009-10-22 | Shorr Robert G L (Director) | Sale | 30,000 | .34 | 10,050 |
| 2009-10-21 | Shorr Robert G L (Director) | Sale | 25,000 | .29 | 7,249 |
| 2009-10-20 | Shorr Robert G L (Director) | Sale | 50,000 | .28 | 14,000 |
| 2009-10-19 | Shorr Robert G L (Director) | Sale | 50,000 | .27 | 13,500 |
| 2009-10-16 | Shorr Robert G L (Director) | Sale | 5,000 | .28 | 1,400 |
| 2009-09-15 | Taub Malcolm S (Director) | Sale | 225,000 | .26 | 59,175 |
| 2009-09-14 | Taub Malcolm S (Director) | Sale | 350,000 | .25 | 87,850 |
| 2008-09-08 | Accbt Corp. (10% Owner) | Option Ex | 4,125,000 | .18 | 750,750 |
| 2008-08-27 | Javitt Jonathan C (Director) | Sale | 40,000 | .25 | 10,000 |
| 2008-04-03 | Accbt Corp. (10% Owner) | Option Ex | 2,000,000 | .18 | 362,000 |
| 2007-11-12 | Accbt Corp. (10% Owner) | Option Ex | 4,125,000 | .18 | 746,625 |
| 2007-09-10 | Accbt Corp. (10% Owner) | Option Ex | 1,181,925 | 11,819.00 | 13,969,171,575 |
| 2007-08-15 | Accbt Corp. (10% Owner) | Buy | 25,000 | 1.06 | 26,600 |
| 2007-08-14 | Accbt Corp. (10% Owner) | Buy | 20,500 | 1.08 | 22,119 |
| 2007-08-13 | Accbt Corp. (10% Owner) | Buy | 45,500 | 1.05 | 47,729 |
| 2007-08-10 | Accbt Corp. (10% Owner) | Buy | 34,000 | .98 | 33,422 |
| 2007-08-10 | Accbt Corp. (10% Owner) | Option Ex | 6,875,000 | .18 | 1,244,375 |
| 2007-08-09 | Accbt Corp. (10% Owner) | Buy | 75,000 | 1.02 | 76,275 |
Insider trading activities including stock purchases, stock sales, and option exercises of BCLI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Brainstorm Cell Therapeutics Inc. (symbol BCLI, CIK number 1137883) see the Securities and Exchange Commission (SEC) website.